TY - JOUR
T1 - A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases
AU - Lee, Anna K.
AU - Potts, Patrick Ryan
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/4/21
Y1 - 2017/4/21
N2 - Melanoma antigen (MAGE) genes are conserved in all eukaryotes and encode for proteins sharing a common MAGE homology domain. Although only a single MAGE gene exists in lower eukaryotes, the MAGE family rapidly expanded in eutherians and consists of more than 50 highly conserved genes in humans. A subset of MAGEs initially garnered interest as cancer biomarkers and immunotherapeutic targets due to their antigenic properties and unique expression pattern that is primary restricted to germ cells and aberrantly reactivated in various cancers. However, further investigation revealed that MAGEs not only drive tumorigenesis but also regulate pathways essential for diverse cellular and developmental processes. Therefore, MAGEs are implicated in a broad range of diseases including neurodevelopmental, renal, and lung disorders, and cancer. Recent biochemical and biophysical studies indicate that MAGEs assemble with E3 RING ubiquitin ligases to form MAGE-RING ligases (MRLs) and act as regulators of ubiquitination by modulating ligase activity, substrate specification, and subcellular localization. Here, we present a comprehensive guide to MAGEs highlighting the molecular mechanisms of MRLs and their physiological roles in germ cell and neural development, oncogenic functions in cancer, and potential as therapeutic targets in disease.
AB - Melanoma antigen (MAGE) genes are conserved in all eukaryotes and encode for proteins sharing a common MAGE homology domain. Although only a single MAGE gene exists in lower eukaryotes, the MAGE family rapidly expanded in eutherians and consists of more than 50 highly conserved genes in humans. A subset of MAGEs initially garnered interest as cancer biomarkers and immunotherapeutic targets due to their antigenic properties and unique expression pattern that is primary restricted to germ cells and aberrantly reactivated in various cancers. However, further investigation revealed that MAGEs not only drive tumorigenesis but also regulate pathways essential for diverse cellular and developmental processes. Therefore, MAGEs are implicated in a broad range of diseases including neurodevelopmental, renal, and lung disorders, and cancer. Recent biochemical and biophysical studies indicate that MAGEs assemble with E3 RING ubiquitin ligases to form MAGE-RING ligases (MRLs) and act as regulators of ubiquitination by modulating ligase activity, substrate specification, and subcellular localization. Here, we present a comprehensive guide to MAGEs highlighting the molecular mechanisms of MRLs and their physiological roles in germ cell and neural development, oncogenic functions in cancer, and potential as therapeutic targets in disease.
KW - E3 ligases
KW - MAGE
KW - cancer-testis antigens
KW - ubiquitin
UR - http://www.scopus.com/inward/record.url?scp=85016502573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016502573&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2017.03.005
DO - 10.1016/j.jmb.2017.03.005
M3 - Review article
C2 - 28300603
AN - SCOPUS:85016502573
SN - 0022-2836
VL - 429
SP - 1114
EP - 1142
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 8
ER -